Optimal Treatment Strategies for Community-Acquired Pneumonia: High-Risk Patients (Geriatric and with Comorbidity)

Publisher： Karger

E-ISSN： 1421-9794|47|4|19-25

ISSN： 0009-3157

Source： Chemotherapy, Vol.47, Iss.4, 2001-09, pp. : 19-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Treatment Strategies for Community-Acquired Pneumonia: Non-Responders to Conventional Regimens

By  

Chemotherapy, Vol. 47, Iss. 4, 2001-09 ,pp. : 11-18

Karger

Access to resources Recommend Favorite

Treatment of Community-Acquired Pneumonia

By  

Chemotherapy, Vol. 46, Iss. 1, 2000-05 ,pp. : 24-31

Karger

Access to resources Recommend Favorite

Optimal Treatment Strategies for Acute Exacerbations of Chronic Bronchitis: High-Risk Patients

By  

Chemotherapy, Vol. 47, Iss. 4, 2001-09 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Vitamin D Level and Risk of Community-Acquired Pneumonia and Sepsis

By Jovanovich Anna J.   Ginde Adit A.   Holmen John   Jablonski Kristen   Allyn Rebecca L.   Kendrick Jessica   Chonchol Michel  

Nutrients, Vol. 6, Iss. 6, 2014-06 ,pp. : 2196-2205

MDPI

Access to resources Recommend Favorite

Experience with Levofloxacin in a Critical Pathway for the Treatment of Community-Acquired Pneumonia

By  

Chemotherapy, Vol. 50, Iss. 1, 2004-08 ,pp. : 11-15

Karger

Access to resources Recommend Favorite